Schedule 13G ownership disclosure
Avidity Biosciences Inc
Common Stock · CUSIP: 05370A108
Event date: 2025-03-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Wellington Management Group LLP
Shares: 9,684,556.00 · Class: 8.1%
- Wellington Group Holdings LLP
Shares: 9,684,556.00 · Class: 8.1%
- Wellington Investment Advisors Holdings LLP
Shares: 9,684,556.00 · Class: 8.1%
- Wellington Management Company LLP
Shares: 9,684,556.00 · Class: 7.5%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000902219-25-000173
- Form type
- SCHEDULE 13G/A
- Filer
- Avidity Biosciences, Inc.
- CIK
- CIK 1599901
- Filed
- May 12, 2025
- Reporting period
- Mar 31, 2025
- Description
- Schedule 13G beneficial ownership